companiesCompany
Leadiant Biosciences
Leadiant Biosciences (formerly Sigma-Tau) is an Italian rare-disease company that holds the US application for procarbazine (Matulane).
Overview
Leadiant markets niche and rare-disease products including Matulane (procarbazine) for Hodgkin lymphoma, pegademase and cysteamine formulations.
Headquarters
Rome, IT
Scorecard
All companies#100of 680 companies, score 26
- approved products +6
- modalities +2
- regions +1
- registry trials +17
1 approved, 0 in phase 3, 0 earlier, 0 targets, 73 registry studies. Formula on the scorecards page.
Type
pharma
Website